Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.8K Sell
170
-5
-3% -$1.07K 0.02% 391
2026
Q1
$38.7K Buy
175
+6
+4% +$1.47K 0.03% 329
2025
Q4
$42.8K Sell
169
-74
-30% -$18.6K 0.03% 329
2025
Q3
$60.1K Buy
243
+31
+15% +$7.42K 0.05% 250
2025
Q2
$50.9K Buy
212
+110
+108% +$25.6K 0.04% 270
2025
Q1
$23.1K Sell
102
-87
-46% -$19.1K 0.02% 438
2024
Q4
$38.9K Buy
+189
New +$41.5K 0.04% 336

Other funds holding STE

WPG Advisers's STE Position: Q2 2026 in Review

WPG Advisers reduced its Steris (STE) stake by 2.9% in Q2 2026, selling an estimated $1.07K and leaving 170 shares worth $35.8K. The position accounts for 0.02% of the portfolio, ranked #391.

WPG Advisers first reported a position in STE in Q4 2024 and has held it in 7 quarters since. The position peaked at $60.1K in Q3 2025. 425 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • WPG Advisers held 170 shares of Steris worth $35.8K as of Q2 2026.
  • WPG Advisers sold 5 Steris shares in Q2 2026, an estimated $1.07K.
  • Steris made up 0.02% of WPG Advisers's portfolio in Q2 2026, its #391 holding.
  • WPG Advisers first reported a position in Steris in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Steris position peaked at $60.1K in Q3 2025.
  • 425 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.